Menlo Park, California, United States The venture was found in North America in United States. The main department of described VC is located in the Menlo Park.
The high activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this HealthQuest Capital performs on 15 percentage points less the average number of lead investments. Considering the real fund results, this VC is 34 percentage points more often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the HealthQuest Capital, startups are often financed by Sofinnova Investments, BioStar Ventures, Aisling Capital. The meaningful sponsors for the fund in investment in the same round are Aisling Capital, Safeguard Scientifics, Polaris Partners. In the next rounds fund is usually obtained by Silicon Valley Bank, Smith & Nephew, Safeguard Scientifics.
Besides them, we counted 5 critical employees of this fund in our database.
The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Health Care. Among the various public portfolio startups of the fund, we may underline Ajax Health, Magnolia Medical Technologies, Trice Medical
Related Funds
Funds with similar focus
| Fund Name | Location |
| Aurora Private Equity | Aberdeen, Scotland, United Kingdom |
| ChimeraBio | Dundee, Dundee City, United Kingdom |
| China Resources | China, Hong Kong, Hong Kong Island |
| Equus Total Return,Inc. | Houston, Texas, United States |
| Frontier Growth | Charlotte, North Carolina, United States |
| Fujikura | Japan, Koto |
| Future Planet Capital | England, London, United Kingdom |
| Hexcel Corporation | Connecticut, Stamford, United States |
| KOEI TECMO HOLDINGS | Japan, Kanagawa Prefecture, Yokohama |
| Lingshi Touzi | China, Guangdong, Shenzhen |
| Manipal Hospitals | Bangalore, India, Karnataka |
| ProQuest | Ann Arbor, Michigan, United States |
| RockBridge Capital Partners | Columbus, Ohio, United States |
| Serve Credit Union | Des Moines, Iowa, United States |
| STC Ventures | Dubai, United Arab Emirates |
| SulzerMedica USA | - |
| Telecom Infra Project | California, Menlo Park, United States |
| The Jagen Group | Australia, Melbourne, Victoria |
| The Singer Group | Maryland, Reisterstown, United States |
| WRV Capital | California, Menlo Park, United States |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Clearsense | $50M | 31 Jan 2023 | Florida, United States | ||
Perspectum | $42M | 05 Jan 2023 | Oxford, England, United Kingdom | ||
Venus Concept | $6M | 18 Nov 2022 | Old Toronto, Ontario, Canada | ||
Nomad Health | $105M | 27 Jun 2022 | New York, New York, United States | ||
Magnolia Medical Technologies | $46M | 16 Feb 2022 | Seattle, Washington, United States | ||
Lunit | $61M | 29 Nov 2021 | South Korea, Gyeonggi-do, South Korea | ||
RareCyte | $24M | 09 Sep 2021 | Seattle, Washington, United States | ||
Thirty Madison | $140M | 02 Jun 2021 | New York, New York, United States | ||
EverlyWell | $75M | 17 Jan 2021 | Austin, Texas, United States |
– Thirty Madison, a New York-based healthcare company that focuses on people with chronic conditions, raised $140M in Series C funding.
– The round was led by new investor HealthQuest Capital with participation from Mousse Partners and Bracket Capital and existing investors Polaris Partners, Johnson & Johnson Innovation – JJDC, Inc., Northzone, Greycroft, and others.
– The company intends to use the funds to expand access to its care model for people who suffer from chronic conditions and enhance the capabilities of its proprietary platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Clearsense | $50M | 31 Jan 2023 | Florida, United States | ||
Perspectum | $42M | 05 Jan 2023 | Oxford, England, United Kingdom | ||
Venus Concept | $6M | 18 Nov 2022 | Old Toronto, Ontario, Canada | ||
Nomad Health | $105M | 27 Jun 2022 | New York, New York, United States | ||
Magnolia Medical Technologies | $46M | 16 Feb 2022 | Seattle, Washington, United States | ||
Lunit | $61M | 29 Nov 2021 | South Korea, Gyeonggi-do, South Korea | ||
RareCyte | $24M | 09 Sep 2021 | Seattle, Washington, United States | ||
Thirty Madison | $140M | 02 Jun 2021 | New York, New York, United States | ||
EverlyWell | $75M | 17 Jan 2021 | Austin, Texas, United States |
Get matched with relevant funds
